CHYMOTRYSPINOGEN

Chymotrypsinogen is the inactive precursor of chymotrypsin, activated enzymatically in research and pharmaceutical applications. Exposure risks include mild irritation or hypersensitivity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 1f90f7c220da Category: Tag:

Product Description


Mechanism of Action

Chymotrypsinogen is the inactive zymogen precursor of chymotrypsin. It is activated by trypsin via cleavage of specific peptide bonds, producing chymotrypsin. Structural studies of the zymogen reveal conformational changes that enable catalytictriad activation upon processing.

Benefits and Advantages

Used in enzymeactivation research, zymogenconversion studies, structuralbiology analysis, proteasecascade modelling and proteinfolding research.

Side Effects and Risks

Risks include sensitisation, respiratory irritation and enzymatic tissue interaction. Handle with standard proteasezymogen precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

Protein

Molecular Weight

25000.0 g/mol

CAS Number

2594868

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

Protein structure — no IUPAC

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download